High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$10.7M
$10,737,871
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$39,904
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $39,904 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$75,317
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $75,317 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$48,041
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $48,041 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-05
$49,915
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-05 | $49,915 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$31,009
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $31,009 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$68,006
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $68,006 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$24,366
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $24,366 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$18,563
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $18,563 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$9,252
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $9,252 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$8,960
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $8,960 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$18,928
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $18,928 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-04
$25,424
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-04 | $25,424 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$91,483
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $91,483 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$89,851
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $89,851 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$231,408
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $231,408 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-03-03
$115,447
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-03-03 | $115,447 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$84,013
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $84,013 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$128,110
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $128,110 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$107,803
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $107,803 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$32,871
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $32,871 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$56,051
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $56,051 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$26,799
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $26,799 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$31,201
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $31,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$12,308
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $12,308 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$15,210
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $15,210 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-03-02
$29,218
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-03-02 | $29,218 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-02-17
$677,532
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-02-17 | $677,532 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-02-13
$607,448
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-02-13 | $607,448 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$104,420
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $104,420 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$45,668
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $45,668 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$72,401
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $72,401 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$238,280
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $238,280 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$207,243
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $207,243 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2026-01-13
$180,051
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2026-01-13 | $180,051 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$72,601
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $72,601 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$17,087
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $17,087 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$26,454
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $26,454 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$35,422
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $35,422 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$55,834
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $55,834 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$30,527
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $30,527 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$44,056
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $44,056 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$34,288
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $34,288 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$14,600
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $14,600 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$14,917
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $14,917 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$13,804
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $13,804 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$18,320
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $18,320 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$33,913
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $33,913 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$15,063
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $15,063 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$14,779
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $14,779 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$7,047
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $7,047 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$745
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $745 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$5,242
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $5,242 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$7,137
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $7,137 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$5,667
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $5,667 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2026-01-12
$80,423
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2026-01-12 | $80,423 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$325,814
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $325,814 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 SellΔOwn -24.5%
2025-11-17
$3,667,432Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 SellΔOwn -24.5%
|
2025-11-17 | $3,667,432Large | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$43,209
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $43,209 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$58,245
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $58,245 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$167,528
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $167,528 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$166,075
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $166,075 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$119,836
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $119,836 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$363,978
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $363,978 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$286,052
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $286,052 | S | Form 4 |
|
ALNY
M
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Other
2025-11-17
$972,220
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Other
|
2025-11-17 | $972,220 | M | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$149,213
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $149,213 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
10b5-1 Sell
2025-11-17
$136,609
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
10b5-1 Sell
|
2025-11-17 | $136,609 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$1,373
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $1,373 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$55,806
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $55,806 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$27,349
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $27,349 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$92,333
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $92,333 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$123,879
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $123,879 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$251,243
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $251,243 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$124,713
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $124,713 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$202,414
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $202,414 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$93,107
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $93,107 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$67,316
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $67,316 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$21,052
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $21,052 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Fitzgerald Kevin Joseph
• Officer • CSO & EVP, Head of Research
Sell to Cover
2025-10-02
$42,867
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • CSO & EVP, Head of Research
Sell to Cover
|
2025-10-02 | $42,867 | S | Form 4 |